Marchesini Group, an expert in pharmaceutical packaging machinery, and AST, a U.S specialist in the drug product manufacturing industry, have entered a strategic partnership that combines the expertise, technologies, and global reach of two highly respected industry leaders. The partnership will strengthen their position in sterile fill-finish production by delivering increasingly advanced, integrated and comprehensive solutions. This agreement will provide both companies with greater production capacity and an extended global network for technical assistance and support, while consolidating distribution networks and sales channels across North America, Europe, Asia, and other strategic regions.
The partnership will enable the development of sophisticated technologies, driven by a shared vision: creating value for customers, expanding market presence and fostering innovation. Specifically, Marchesini Group has acquired a 44.39% equity stake in AST, further enriching its portfolio of aseptic packaging solutions. AST’s technologies, advanced aseptic filling and closing systems for the pharmaceutical and biotech industries, will complement those of the Group’s two production plants: Corima, the Tuscan excellence that is a benchmark in Italy for sterile product filling, and MAR, specialized in precision filling and capping machines for liquid and powder products.
